The cost associated with administering risperidone long-acting injections in the Australian community

BACKGROUND: Risperidone long-acting injection (LAI) is mostly administered twice weekly to people with schizophrenia by nurses at community mental health centres (CMHC) or through mobile outreach visits. This study estimates the cost of resource utilisation associated with the administration of risp...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalton, Andrew, Lambert, Tim, Schrover, Rudolf, Hertel, Judy, Smith, Dell Kingsford
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189877/
https://www.ncbi.nlm.nih.gov/pubmed/21943060
http://dx.doi.org/10.1186/1472-6963-11-236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189877/
https://www.ncbi.nlm.nih.gov/pubmed/21943060
http://dx.doi.org/10.1186/1472-6963-11-236

Ejemplares similares